These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29985717)

  • 1. Defective Treg response in acute kidney injury was caused by a reduction in TIM-3
    Dong Q; Cai C; Gao F; Chen P; Gong W; Shen M
    Immunol Invest; 2019 Jan; 48(1):27-38. PubMed ID: 29985717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overrepresentation of highly functional T regulatory cells in patients with nonfunctioning pituitary adenoma.
    Han S; Ma E; Jiang W; Lu Y; Sun X; Feng S
    Hum Immunol; 2020 Jun; 81(6):314-319. PubMed ID: 32279926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunction of regulatory T cells in patients with ankylosing spondylitis is associated with a loss of Tim-3.
    Wang M; Liu C; Bond A; Yang J; Zhou X; Wang J; Ji B
    Int Immunopharmacol; 2018 Jun; 59():53-60. PubMed ID: 29625390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with intracranial aneurysms presented defects in regulatory T cells, which were associated with impairment in Tim-3 upregulation.
    Zhang HF; Liang GB; Zhao MG; Zhao GF; Luo YH
    Int Immunopharmacol; 2018 Nov; 64():350-355. PubMed ID: 30243071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tim3
    Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
    Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of LAG3 and TIM3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients.
    Ma Q; Liu J; Wu G; Teng M; Wang S; Cui M; Li Y
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1002-1009. PubMed ID: 29905955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
    Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
    Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble galectin 9 potently enhanced regulatory T-cell formation, a pathway impaired in patients with intracranial aneurysm.
    Zhao MG; Liang GB; Zhang HF; Zhao GF; Luo YH
    Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1206-1212. PubMed ID: 29978574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical stoichiometric ratio of CD4(+)  CD25(+)  FoxP3(+) regulatory T cells and CD4(+)  CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia.
    Bhattacharya K; Chandra S; Mandal C
    Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of regulatory characteristics in CD4
    Bian LQ; Mao L; Bi Y; Zhou SW; Chen ZD; Wen J; Shi J; Wang L
    APMIS; 2017 Dec; 125(12):1108-1116. PubMed ID: 28913840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
    Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
    Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+CD25+ regulatory T cells in patients with Behçet's disease.
    Hamzaoui K; Hamzaoui A; Houman H
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S71-8. PubMed ID: 17067431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of regulatory T cells by physiological level estrogen.
    Tai P; Wang J; Jin H; Song X; Yan J; Kang Y; Zhao L; An X; Du X; Chen X; Wang S; Xia G; Wang B
    J Cell Physiol; 2008 Feb; 214(2):456-64. PubMed ID: 17654501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro induction of functional allergen-specific CD4+ CD25high Treg cells in horses affected with insect bite hypersensitivity.
    Hamza E; Akdis CA; Wagner B; Steinbach F; Marti E
    Clin Exp Allergy; 2013 Aug; 43(8):889-901. PubMed ID: 23889243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant Recipient Circulating CD4+CD127lo/- Tumor Necrosis Factor Receptor 2+ Regulatory T Cells: A Surrogate of Regulatory T Cell-Suppressive Function and Predictor of Delayed and Slow Graft Function After Kidney Transplantation.
    Nguyen MT; Fryml E; Sahakian SK; Liu S; Cantarovich M; Lipman M; Tchervenkov JI; Paraskevas S
    Transplantation; 2016 Feb; 100(2):314-24. PubMed ID: 26425877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.